STAAR Surgical Company Insiders

STAA Stock  USD 17.36  0.09  0.52%   
STAAR Surgical employs about 1.2 K people. The company is managed by 18 executives with a total tenure of roughly 58 years, averaging almost 3.0 years of service per executive, having 64.28 employees per reported executive. Analysis of STAAR Surgical's management performance can provide insight into the company performance.
Caren Mason  Chairman
CEO and President Director and Chairman of Quality and Regulatory Committee
HansMartin Blickensdoerfer  President
President International Commercial Operations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

STAAR Surgical Management Team Effectiveness

The company has return on total asset (ROA) of (0.059) % which means that it has lost $0.059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1914) %, meaning that it created substantial loss on money invested by shareholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities.

STAAR Surgical Workforce Comparison

STAAR Surgical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 158,089. STAAR Surgical maintains roughly 1,157 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.81) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.81.

STAAR Surgical Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, STAAR Surgical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

STAAR Surgical Notable Stakeholders

A STAAR Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as STAAR Surgical often face trade-offs trying to please all of them. STAAR Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting STAAR Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas FrinziCEO PresidentProfile
Stephen CFACEO PresidentProfile
Caren MasonCEO and President Director and Chairman of Quality and Regulatory CommitteeProfile
HansMartin BlickensdoerferPresident International Commercial OperationsProfile
Samuel GestenVice President General Counsel, Corporate Compliance Officer and SecretaryProfile
Keith HollidayVice President - Research & DevelopmentProfile
Philippe SubrinVice President - Switzerland OperationsProfile
James FranceseVP of Global MarketingProfile
Nancy SabinChief OfficerProfile
Brian MooreIR Contact OfficerProfile
Warren FoustChief OfficerProfile
Deborah AndrewsInterim OfficerProfile
Joanne EgaminoGlobal OperationsProfile
Patrick WilliamsChief OfficerProfile
Robert StudholmeSenior OperationsProfile
Scott MDChief OfficerProfile
Nathaniel EsqGeneral SecretaryProfile
Magda MichnaRegulatory ClinicalProfile

About STAAR Surgical Management Performance

The success or failure of an entity such as STAAR Surgical often depends on how effective the management is. STAAR Surgical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of STAAR management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the STAAR management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people.
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.

STAAR Surgical Workforce Analysis

Traditionally, organizations such as STAAR Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare STAAR Surgical within its industry.

STAAR Surgical Manpower Efficiency

Return on STAAR Surgical Manpower

Revenue Per Employee271.3K
Revenue Per Executive17.4M
Net Loss Per Employee17.5K
Net Loss Per Executive1.1M
Working Capital Per Employee257.2K
Working Capital Per Executive16.5M

Complementary Tools for STAAR Stock analysis

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets